Product Information
LEUPROLIDE 2WK 14 MG/2.8 ML KT is a generic product labeled by Sandoz Inc., priced at $197.6060 per EA under NDC 00781400332. Its NADAC has been published 115 times since Apr 17, 2024.
Manufacturer
Sandoz Inc.NDC
00781400332
Classification
Generic
Dosage Form
KIT
Last Updated
5/20/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA074728On Market Since
8/4/1998
Price Statistics
The NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 14.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $197.6060 per EA |
|---|---|
| All-time high | $301.8717 (Sep 10, 2025) |
| All-time low | $197.6060 (May 20, 2026) |
| 52-week high | $301.8717 |
| 52-week low | $197.6060 |
| Median price | $258.8691 |
| Average price | $257.4307 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEUPROLIDE 2WK 14 MG/2.8 ML KT?
The current National Average Drug Acquisition Cost (NADAC) for LEUPROLIDE 2WK 14 MG/2.8 ML KT, manufactured by Sandoz Inc., is $197.6060 per EA (NDC 00781400332), effective Jun 24, 2026.
How has the price of LEUPROLIDE 2WK 14 MG/2.8 ML KT changed over time?
Over the history we have for it, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has declined 14.2%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LEUPROLIDE 2WK 14 MG/2.8 ML KT?
Since Apr 17, 2024, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has ranged from a low of $197.6060 (May 20, 2026) to a high of $301.8717 (Sep 10, 2025), with a median of $258.8691 per EA.
Are there cheaper alternatives to LEUPROLIDE 2WK 14 MG/2.8 ML KT?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LEUPROLIDE 2WK 14 MG/2.8 ML KT, but none are currently priced below it.
Who manufactures LEUPROLIDE 2WK 14 MG/2.8 ML KT?
LEUPROLIDE 2WK 14 MG/2.8 ML KT (NDC 00781400332) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification